100.00% -0.735

Avenue Therapeutics Inc (ATXI)

Panoramica Notizia Cronologia dei prezzi Financials Perché ATXI Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Avenue Therapeutics Inc Stock (ATXI) Company Profile

Avenue Therapeutics Inc

Healthcare (1112)

Biotechnology (621)

Prossima data di guadagno

Ultimi documenti SEC

ATXI's Discussions on Twitter

Compare ATXI vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATXI Avenue Therapeutics Inc	0.00	0	0	-10.38M	-12.45M	-3.81
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Avenue Therapeutics Inc Borsa (ATXI) Ultime notizie

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc Stock (ATXI) Company Profile

Compare ATXI vs VRTX, REGN, ARGX, ALNY, ONC

Avenue Therapeutics Inc Borsa (ATXI) Ultime notizie

Cullinan Therapeutics (NASDAQ:CGEM) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Edgewise Therapeutics (NASDAQ:EWTX) Downgraded by Wall Street Zen to Sell - MarketBeat

VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - The Joplin Globe

Axsome Therapeutics says AXS-12 NDA submission on track for January - MSN

Century Therapeutics (NASDAQ:IPSC) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Cullinan Therapeutics (NASDAQ:CGEM) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Esperion Therapeutics (NASDAQ:ESPR) Raised to "Buy" at Wall Street Zen - MarketBeat

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Up 481.9% in January - Defense World

Analyzing Turn Therapeutics (TTRX) & The Competition - Defense World

HCA Healthcare (NYSE:HCA) Shares Gap Up After Earnings Beat - Defense World

Boku (LON:BOKU) Insider Jonathan Peter Prideaux Sells 325,000 Shares of Stock - Defense World

Huge Waltham lab lease fuels work on potential Dravet syndrome drug - Stock Titan

Century Therapeutics (NASDAQ:IPSC) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Pacific Heights Asset Management LLC Raises Stake in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Fate Therapeutics (NASDAQ:FATE) Stock Price Crosses Above 50-Day Moving AverageHere's What Happened - MarketBeat

Maze Therapeutics (NASDAQ:MAZE) Cut to "Sell" at Wall Street Zen - MarketBeat

More cash flows into biotechs during conference week: Finance Report - biocentury.com

Aptevo Therapeutics (NASDAQ: APVO) seeks OK for $60M SEPA share sales - Stock Titan

Market Recap: Can Ernexa Therapeutics Inc continue delivering strong returnsJuly 2025 PostEarnings & Low Risk High Reward Ideas - baoquankhu1.vn

Avenue Therapeutics shareholders elect directors, ratify KPMG auditor - MSN

Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan

Capricor Therapeutics (NASDAQ:CAPR) Cut to Sell at Wall Street Zen - MarketBeat

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to "Hold" at Wall Street Zen - MarketBeat

Mersana Therapeutics (NASDAQ:MRSN) Upgraded at Wall Street Zen - MarketBeat

Karyopharm (NASDAQ: KPTI) plans big share authorization increase to fund 2026 trials - stocktitan.net

Is PTC Therapeutics Inc. stock a defensive play in 20252025 Price Targets & Smart Investment Allocation Tips - Улправда

Capricor Therapeutics (NASDAQ:CAPR) Upgraded at Wall Street Zen - MarketBeat

PTC Therapeutics (NASDAQ:PTCT) Upgraded to Buy at Wall Street Zen - MarketBeat

Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates - ADVFN

Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting - ADVFN

Avenue Therapeutics (ATXI) investors reelect six directors and ratify KPMG for 2025 - Stock Titan

Axsome Therapeutics shares gain 1.4% premarket after FDA grants priority review for co's Alzheimer's agitation drug - marketscreener.com

FDA supports Axsome’s NDA submission for narcolepsy drug AXS-12 By Investing.com - Investing.com Australia

ATXI: All directors were elected and KPMG LLP was ratified as auditor for 2025 - TradingView — Track All Markets

ATXI: All director nominees were elected and KPMG LLP was ratified as auditor for 2025 - TradingView — Track All Markets

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dyne Therapeutics (NASDAQ:DYN) Stock Rating Lowered by Wall Street Zen - MarketBeat

vTv Therapeutics (NASDAQ:VTVT) Upgraded at Wall Street Zen - MarketBeat

Vera Therapeutics (VERA) Stock Dips in Thin Post‑Christmas Trading as Wall Street Weighs FDA Filing, $300M Raise, and IgA Nephropathy Competition - TechStock²

NexImmune (NASDAQ:NEXI) versus Avenue Therapeutics (NASDAQ:ATXI) Head-To-Head Comparison - Defense World

The Philippines - AstraZeneca

Avenue Therapeutics, Inc.Common Stock (NQ: ATXI - FinancialContent

Form 424B3 Ovid Therapeutics Inc. - StreetInsider

Will Neumora Therapeutics Inc. stock benefit from AI adoptionOil Prices & Weekly Setup with High ROI Potential - Улправда

Axsome Therapeutics stock hits all-time high at 152.98 USD - Investing.com

Axsome Therapeutics stock hits all-time high at 152.98 USD By Investing.com - Investing.com Australia

Axsome Therapeutics (AXSM) Gets a Buy from Jefferies - The Globe and Mail

Avenue Therapeutics (ATXI) plans resale of 731,061 warrant-linked shares - Stock Titan

[RW] AVENUE THERAPEUTICS, INC. SEC Filing - Stock Titan

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ATXI